Since we previously observed increased severity of neurological disease in mice treated with IL-12/18, we compared brain CD8+ T cell NKG2D expression in both PBS and IL-12/18 treated ZIKV-infected mice (Supplementary Fig. 5a). This evidence concerns the gene CD8A and nervous system disorder.